المؤلفون: Hollis RL, Churchman M, Gourley C

المصدر: OncoTargets and Therapy, Vol Volume 10, Pp 2539-2551 (2017)

مصطلحات موضوعية: Ovarian cancer, BRCA1, BRCA2, BRCAness, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.dovepress.com/distinct--implications-of-different-brca-mutations-efficacy-of-cytotox-peer-reviewed-article-OTT; https://doaj.org/toc/1178-6930

URL الوصول: https://doaj.org/article/57e1455b31e04f0f820294a2ba01bc50

المؤلفون: Irodi, A, Rye, T, Herbert, K, Churchman, M, Bartos, C, Mackean, M, Nussey, F, Herrington, CS, Gourley, C, Hollis, RL, Herrington, C S, Hollis, R L

المصدر: BJOG: An International Journal of Obstetrics & Gynaecology; Oct2020, Vol. 127 Issue 11, p1409-1420, 12p

مصطلحات موضوعية: OVARIAN epithelial cancer, CANCER patients, PROGNOSIS, PROGRESSION-free survival, DISEASE relapse, SURVIVAL analysis (Biometry), RESEARCH, OVARIAN tumors, RESEARCH methodology, RETROSPECTIVE studies, ACQUISITION of data, EVALUATION research, MEDICAL cooperation, TUMOR classification, COMPARATIVE studies, KAPLAN-Meier estimator, AGE factors in disease, RESEARCH funding, CYTOREDUCTIVE surgery, TUMOR grading

مصطلحات جغرافية: SCOTLAND

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Taylor SJ; Edinburgh Pathology, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom. Electronic address: sarah.taylor-2@ed.ac.uk., Hollis RL; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom., Gourley C; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom., Herrington CS; Edinburgh Pathology, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom., Langdon SP; Edinburgh Pathology, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom., Arends MJ; Edinburgh Pathology, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom. Electronic address: m.arends@ed.ac.uk.

المصدر: Experimental and molecular pathology [Exp Mol Pathol] 2024 Aug; Vol. 138, pp. 104916. Date of Electronic Publication: 2024 Jul 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0370711 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-0945 (Electronic) Linking ISSN: 00144800 NLM ISO Abbreviation: Exp Mol Pathol Subsets: MEDLINE

مواضيع طبية MeSH: Fanconi Anemia Complementation Group D2 Protein*/genetics , Fanconi Anemia Complementation Group D2 Protein*/metabolism , Ovarian Neoplasms*/genetics , Ovarian Neoplasms*/pathology , Ovarian Neoplasms*/drug therapy , Ovarian Neoplasms*/metabolism , Drug Resistance, Neoplasm*/genetics , Carboplatin*/pharmacology , Carboplatin*/therapeutic use , Cystadenocarcinoma, Serous*/genetics , Cystadenocarcinoma, Serous*/pathology , Cystadenocarcinoma, Serous*/drug therapy , Cystadenocarcinoma, Serous*/metabolism, Humans ; Female ; Cell Line, Tumor ; Gene Expression Regulation, Neoplastic ; TOR Serine-Threonine Kinases/genetics ; TOR Serine-Threonine Kinases/metabolism ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Cell Movement/genetics ; Neoplasm Grading ; Platinum/pharmacology ; Platinum/therapeutic use